Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00283946
Status:
COMPLETED
Last Update Posted:
2014-08-20
First Post:
2006-01-30
Brief Title:
A Double-blind Group-comparison Study Using Zolpidem Myslee as a Comparative Drug in Patients With Insomnia
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Study Overview
Official Title:
FK199B Zolpidem MR Tablet Phase III Clinical Study -A Double-blind Group-comparison Study Using Zolpidem Myslee as a Comparative Drug in Patients With Insomnia -
Status:
COMPLETED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the efficacy and safety of FK199B Zolpidem MR Tablet in patients with insomnia by a randomized double-blind group-comparison study using zolpidem Myslee as a comparative drug
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None